IL17A and tuberculosis: Interestingly, as recently reviewed, IL-17 acts as an effector molecule similar to IFN-γ after BCG vaccination and M. tuberculosis infection, contributing to protection against active TB depending or not on IFN-γ (Li et al., 2012).